RAC supplies reference standards for 3 Lodoxamide impurities, including Lodoxamide Impurity 1 and Lodoxamide Impurity 2. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| 标准品 | CAS | 状态 | |
|---|---|---|---|
| Lodoxamide Impurity 1 | 66223-75-4 | 合成中 | |
| Lodoxamide Impurity 2 | 55441-26-4 | 合成中 | |
| Lodoxamide Impurity 3 | 617-36-7 | 合成中 |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI 亚硝胺s and degradation products of Lodoxamide that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.
—